Treatment of ascites and spontaneous bacterial peritonitis - part I

Dan Med J. 2012 Jan;59(1):C4371.

Abstract

National guidelines for treatment of ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, and hyponatremia have been approved by the Danish Society of Gastroenterology and Hepatology. Ascites develops in approximately 60% of patients with cirrhosis during a 10 year period and is frequently associated with complications that determine the course of the disease and the prognosis. These evidence-based guidelines are divided in two parts and consider definitions, pathophysiology, diagnostic aspects, treatment, and prophylaxis.

Publication types

  • Practice Guideline

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Ascites* / diagnosis
  • Ascites* / etiology
  • Ascites* / metabolism
  • Ascites* / physiopathology
  • Ascites* / therapy
  • Ascitic Fluid / metabolism
  • Ascitic Fluid / microbiology
  • Bacterial Infections / diagnosis
  • Bacterial Infections / microbiology
  • Bacterial Infections / physiopathology
  • Bacterial Infections / therapy
  • Clinical Protocols / standards
  • Combined Modality Therapy
  • Diuretics / therapeutic use*
  • Evidence-Based Medicine / standards
  • Humans
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / physiopathology
  • Microbial Sensitivity Tests
  • Paracentesis / methods*
  • Peritonitis* / diagnosis
  • Peritonitis* / microbiology
  • Peritonitis* / physiopathology
  • Peritonitis* / therapy
  • Suppuration / complications
  • Suppuration / physiopathology

Substances

  • Anti-Bacterial Agents
  • Diuretics